Patent · US Active

Enalapril compositions

US8568747B1 · kind B1 · utility

25Cited by

12References

6Claims

0Family size

Assignees

SILVERGATE PHARMACEUTICALS, INC. · US
University of Kansas · US

Inventors

Lian G. Rajewski · Lawrence, US
Roger A. Rajewski · Lawrence, US
John L. Haslam · Lawrence, US
Kathleen Heppert · Lawrence, US
Michael C. Beckloff · Leawood, US
Frank Seagrave · Dublin, US
Robert Mauro · Miller Place, US
Peter Colabuono · Las Vegas, US

Key dates

Filing date	Nov 6, 2012
Grant date	Oct 29, 2013
Priority date	—
Expiry date	Nov 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.